Danaher Corp. (DHR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1153025,
    "name": "Danaher Corp.",
    "stock_name": "Danaher Corp.",
    "full_name": "Danaher Corp.",
    "name_url": "stocks-analysis/danaher-corp",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "227.13",
    "chg": -1.33,
    "chgp": "-0.58%",
    "dir": -1,
    "prev_price": "228.46",
    "mcapval": "170,176.57",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US2358511028",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "8.18 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/danaher-corp-1153025-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Danaher Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-danaher-corp-technically-bullish-or-bearish-3673509",
        "imagepath": "",
        "date": "2025-11-05 11:18:26",
        "description": "As of 31 October 2025, the technical trend for Danaher Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The daily moving averages are also bullish, supporting the upward trend. However, the monthly Bollinger Bands are bearish, which suggests some caution. The KST shows a bullish stance on the weekly timeframe but is bearish monthly, indicating mixed signals. Overall, the Dow Theory indicates a mildly bullish trend on the weekly basis with no trend monthly.\n\nIn terms of performance, Danaher has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.85% compared to the S&P 500's 16.30%, and a one-year return of -13.69% versus 19.89% for the benchmark. This underperformance highlights the need for careful consideration despite the current mildly bullish technical stance...."
      },
      {
        "title": "Is Danaher Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-danaher-corp-technically-bullish-or-bearish-3670713",
        "imagepath": "",
        "date": "2025-11-04 11:29:50",
        "description": "As of 31 October 2025, the technical trend for Danaher Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD remains bearish, indicating mixed signals across time frames. The daily moving averages are bullish, supporting the current positive trend. However, the weekly KST is bullish, and the monthly KST is bearish, adding to the mixed outlook. The Bollinger Bands show a mildly bullish stance on the weekly chart but are mildly bearish on the monthly chart. Dow Theory indicates a mildly bullish trend on a monthly basis, while the weekly shows no trend. \n\nIn terms of performance, Danaher has underperformed compared to the S&P 500 across all multi-period returns, with a year-to-date return of -6.75% versus the S&P 500's 16.30%, and a one-year return of -13.60% compared to 19.89%. Overall, the current stance is mildly bullish, but caution is warranted given t..."
      },
      {
        "title": "Is Danaher Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-danaher-corp-technically-bullish-or-bearish-3666287",
        "imagepath": "",
        "date": "2025-11-03 11:28:41",
        "description": "As of 31 October 2025, the technical trend for Danaher Corp. has changed from mildly bearish to mildly bullish. The current stance is mildly bullish, driven by a bullish MACD on the weekly timeframe and bullish moving averages on the daily timeframe. However, the monthly MACD and KST remain bearish, indicating mixed signals across different timeframes. The Bollinger Bands show a mildly bullish signal on the weekly but mildly bearish on the monthly, and Dow Theory indicates a mildly bullish stance monthly with no trend weekly. \n\nIn terms of performance, Danaher has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -6.17% versus the S&P 500's 16.30%, and a one-year return of -12.33% compared to 19.89% for the index...."
      },
      {
        "title": "Is Danaher Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-danaher-corp-technically-bullish-or-bearish-3664406",
        "imagepath": "",
        "date": "2025-11-02 11:15:14",
        "description": "As of 31 October 2025, the technical trend for Danaher Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD remains bearish, indicating mixed signals across time frames. The daily moving averages are bullish, supporting the mildly bullish stance. However, the weekly KST is bullish, contrasting with its monthly bearish signal. Bollinger Bands show a mildly bullish condition on the weekly chart but are mildly bearish on the monthly. Dow Theory indicates a mildly bullish trend on the monthly but no trend on the weekly.\n\nIn terms of performance, Danaher Corp. has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.17% compared to the S&P 500's 16.30%, and a one-year return of -12.33% versus 19.89% for the index. Overall, the current technical stance is mildly bullish, but the stock's performance relative to the benchmark sug..."
      },
      {
        "title": "Danaher Corp. Faces Valuation Shift Amid Declining Financial Performance and Profit Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/danaher-corp-stock-downgraded-to-sell-amid-high-valuations-and-declining-profits-3640167",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/DanaherCorp_mojoScore_3640167.png",
        "date": "2025-10-23 15:37:00",
        "description": "Danaher Corp., a key player in the Pharmaceuticals & Biotechnology sector, has undergone a valuation grade adjustment, now classified as very expensive. Key financial metrics include a P/E ratio of 40 and a Price to Book Value of 3.30, amid challenges like declining profits and flat financial performance."
      },
      {
        "title": "Is Danaher Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-danaher-corp-overvalued-or-undervalued-3637362",
        "imagepath": "",
        "date": "2025-10-21 12:00:47",
        "description": "As of 17 October 2025, the valuation grade for Danaher Corp. has moved from expensive to very expensive, indicating a significant concern regarding its current valuation. The company is overvalued based on its key metrics, which include a P/E ratio of 40, a Price to Book Value of 3.30, and an EV to EBITDA of 24.40. In comparison, Abbott Laboratories, which is considered fairly valued, has a P/E ratio of 18.36, while Thermo Fisher Scientific, also fairly valued, has a P/E ratio of 30.06.\n\nThe stock has underperformed against the S&P 500, with a year-to-date return of -8.93% compared to the S&P 500's 13.30%, and a one-year return of -23.13% versus the S&P 500's 14.08%. This trend reinforces the notion that Danaher Corp. is not only overvalued but also struggling to deliver returns relative to the broader market...."
      },
      {
        "title": "Danaher Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/danaher-corporations-valuation-grade-changes-from-expensive-to-very-expensive-3640610",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/DanaherCorp_valuationdot_3640610.png",
        "date": "2025-10-20 15:52:50",
        "description": "Danaher Corp., a key player in the Pharmaceuticals and Biotechnology sector, has a high P/E ratio of 40, indicating a strong market position. Despite recent outperformance over the S&P 500, the company has faced declines year-to-date and over the past year, contrasting with gains in the broader index."
      },
      {
        "title": "Is Danaher Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-danaher-corp-overvalued-or-undervalued-3631770",
        "imagepath": "",
        "date": "2025-10-19 11:56:17",
        "description": "As of 17 October 2025, the valuation grade for Danaher Corp. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently considered overvalued, with a P/E ratio of 40, a Price to Book Value of 3.30, and an EV to EBIT of 35.55, all of which are substantially higher than many of its peers. For instance, Abbott Laboratories has a P/E of 18.36, while Thermo Fisher Scientific has a P/E of 30.06, both suggesting that Danaher is trading at a premium compared to these companies.\n\nThe recent stock performance further underscores this valuation concern, as Danaher has underperformed against the S&P 500 over multiple periods, including a year-to-date return of -8.93% compared to the S&P 500's 13.30%. This trend continues with a 1-year return of -23.13% against the S&P 500's 14.08%, and a staggering 10-year return of -8.09% compared to 227.77% for t..."
      },
      {
        "title": "Danaher Corp. Experiences Evaluation Revision Amidst Market Challenges and Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/danaher-corp-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-decline-3600952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/DanaherCorp_technicaldot_3600952.png",
        "date": "2025-10-07 19:35:12",
        "description": "Danaher Corp., a key player in the Pharmaceuticals & Biotechnology sector, has recently seen its stock price decline. Over the past year, the company has struggled, significantly underperforming compared to the S&P 500. Technical indicators show mixed signals, reflecting ongoing challenges in the competitive market."
      }
    ],
    "total": 19,
    "sid": "1153025",
    "stock_news_url": "https://www.marketsmojo.com/news/danaher-corp-1153025"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Danaher Corp. technically bullish or bearish?

2025-11-05 11:18:26

As of 31 October 2025, the technical trend for Danaher Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The daily moving averages are also bullish, supporting the upward trend. However, the monthly Bollinger Bands are bearish, which suggests some caution. The KST shows a bullish stance on the weekly timeframe but is bearish monthly, indicating mixed signals. Overall, the Dow Theory indicates a mildly bullish trend on the weekly basis with no trend monthly. In terms of performance, Danaher has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.85% compared to the S&P 500's 16.30%, and a one-year return of -13.69% versus 19.89% for the benchmark. This underperformance highlights the need for careful consideration despite the current mildly bullish technical stance....

Is Danaher Corp. technically bullish or bearish?

2025-11-04 11:29:50

As of 31 October 2025, the technical trend for Danaher Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD remains bearish, indicating mixed signals across time frames. The daily moving averages are bullish, supporting the current positive trend. However, the weekly KST is bullish, and the monthly KST is bearish, adding to the mixed outlook. The Bollinger Bands show a mildly bullish stance on the weekly chart but are mildly bearish on the monthly chart. Dow Theory indicates a mildly bullish trend on a monthly basis, while the weekly shows no trend. In terms of performance, Danaher has underperformed compared to the S&P 500 across all multi-period returns, with a year-to-date return of -6.75% versus the S&P 500's 16.30%, and a one-year return of -13.60% compared to 19.89%. Overall, the current stance is mildly bullish, but caution is warranted given t...

Is Danaher Corp. technically bullish or bearish?

2025-11-03 11:28:41

As of 31 October 2025, the technical trend for Danaher Corp. has changed from mildly bearish to mildly bullish. The current stance is mildly bullish, driven by a bullish MACD on the weekly timeframe and bullish moving averages on the daily timeframe. However, the monthly MACD and KST remain bearish, indicating mixed signals across different timeframes. The Bollinger Bands show a mildly bullish signal on the weekly but mildly bearish on the monthly, and Dow Theory indicates a mildly bullish stance monthly with no trend weekly. In terms of performance, Danaher has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -6.17% versus the S&P 500's 16.30%, and a one-year return of -12.33% compared to 19.89% for the index....

Is Danaher Corp. technically bullish or bearish?

2025-11-02 11:15:14

As of 31 October 2025, the technical trend for Danaher Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD remains bearish, indicating mixed signals across time frames. The daily moving averages are bullish, supporting the mildly bullish stance. However, the weekly KST is bullish, contrasting with its monthly bearish signal. Bollinger Bands show a mildly bullish condition on the weekly chart but are mildly bearish on the monthly. Dow Theory indicates a mildly bullish trend on the monthly but no trend on the weekly. In terms of performance, Danaher Corp. has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.17% compared to the S&P 500's 16.30%, and a one-year return of -12.33% versus 19.89% for the index. Overall, the current technical stance is mildly bullish, but the stock's performance relative to the benchmark sug...

Danaher Corp. Faces Valuation Shift Amid Declining Financial Performance and Profit Challenges

2025-10-23 15:37:00

Danaher Corp., a key player in the Pharmaceuticals & Biotechnology sector, has undergone a valuation grade adjustment, now classified as very expensive. Key financial metrics include a P/E ratio of 40 and a Price to Book Value of 3.30, amid challenges like declining profits and flat financial performance.

Is Danaher Corp. overvalued or undervalued?

2025-10-21 12:00:47

As of 17 October 2025, the valuation grade for Danaher Corp. has moved from expensive to very expensive, indicating a significant concern regarding its current valuation. The company is overvalued based on its key metrics, which include a P/E ratio of 40, a Price to Book Value of 3.30, and an EV to EBITDA of 24.40. In comparison, Abbott Laboratories, which is considered fairly valued, has a P/E ratio of 18.36, while Thermo Fisher Scientific, also fairly valued, has a P/E ratio of 30.06. The stock has underperformed against the S&P 500, with a year-to-date return of -8.93% compared to the S&P 500's 13.30%, and a one-year return of -23.13% versus the S&P 500's 14.08%. This trend reinforces the notion that Danaher Corp. is not only overvalued but also struggling to deliver returns relative to the broader market....

Danaher Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape

2025-10-20 15:52:50

Danaher Corp., a key player in the Pharmaceuticals and Biotechnology sector, has a high P/E ratio of 40, indicating a strong market position. Despite recent outperformance over the S&P 500, the company has faced declines year-to-date and over the past year, contrasting with gains in the broader index.

Is Danaher Corp. overvalued or undervalued?

2025-10-19 11:56:17

As of 17 October 2025, the valuation grade for Danaher Corp. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently considered overvalued, with a P/E ratio of 40, a Price to Book Value of 3.30, and an EV to EBIT of 35.55, all of which are substantially higher than many of its peers. For instance, Abbott Laboratories has a P/E of 18.36, while Thermo Fisher Scientific has a P/E of 30.06, both suggesting that Danaher is trading at a premium compared to these companies. The recent stock performance further underscores this valuation concern, as Danaher has underperformed against the S&P 500 over multiple periods, including a year-to-date return of -8.93% compared to the S&P 500's 13.30%. This trend continues with a 1-year return of -23.13% against the S&P 500's 14.08%, and a staggering 10-year return of -8.09% compared to 227.77% for t...

Danaher Corp. Experiences Evaluation Revision Amidst Market Challenges and Performance Indicators

2025-10-07 19:35:12

Danaher Corp., a key player in the Pharmaceuticals & Biotechnology sector, has recently seen its stock price decline. Over the past year, the company has struggled, significantly underperforming compared to the S&P 500. Technical indicators show mixed signals, reflecting ongoing challenges in the competitive market.

View All News